1. P1135: SUBCUTANEOUS EPCORITAMAB IN COMBINATION WITH RITXUIMAB + LENALIDOMIDE IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PHASE 1/2 TRIAL UPDATE. (23rd June 2022) Authors: Belada, D.; Leppä, S.; Wahlin, B. E.; Nijland, M.; Christensen, J. H.; de Vos, S.; Holte, H.; Linton, K. M.; Abbas, A.; Wang, L.; Dinh, M.; Elliott, B.; Falchi, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1162: ZANUBRUTINIB IN OLDER PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): SUBGROUP ANALYSIS OF THE MAGNOLIA STUDY. (23rd June 2022) Authors: Opat, S.; Hu, B.; Tedeschi, A.; Linton, K. M.; McKay, P.; Chan, H.; Jin, J.; Sun, M.; Sobieraj-Teague, M.; Zinzani, P. L.; Coleman, M.; Browett, P.; Ke, X.; Portell, C. A.; Thieblemont, C.; Ardeshna, K.; Bijou, F.; Walker, P.; Hawkes, E. A.; Ho, S.-J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1049 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1214: SUBCUTANEOUS EPCORITAMAB + R-CHOP FOR FIRST-LINE TREATMENT OF PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: PHASE 1/2 UPDATE. (23rd June 2022) Authors: Clausen, M. R.; Offner, F.; Belada, D.; Brody, J.; Linton, K. M.; Karimi, Y.; Cordoba, R.; Snauwaert, S.; Abbas, A.; Wang, L.; Wu, J.; Elliott, B.; Falchi, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗